Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4438 Target Snapshot

Serine/threonine-protein phosphatase PP1-gamma catalytic subunit · SINGLE PROTEIN · Homo sapiens

32Compounds
34Assays
1Approved Drugs
61.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P36873. Use UniProt P36873 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P36873 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Serine/threonine-protein phosphatase PP1-gamma catalytic subunit as ChEMBL target CHEMBL4438, mapped to UniProt P36873. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4438
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P36873
Serine/threonine-protein phosphatase PP1-gamma catalytic subunit
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Serine/threonine-protein phosphatase PP1-gamma catalytic subunit is the right protein anchor across sources, using UniProt P36873 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSerine/threonine-protein phosphatase PP1-gamma catalytic subunit
UniProt AccessionP36873
Component TypeProtein
Sequence Length323 aa

Serine/threonine-protein phosphatase PP1-gamma catalytic subunit

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Serine/threonine-protein phosphatase PP1-gamma catalytic subunit, mapped to UniProt P36873. Sequence length is 323 aa.

Mapped IDP36873
Review nameSerine/threonine-protein phosphatase PP1-gamma catalytic subunit
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC5050.0
KI10.0
KD1.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL444092 11.0 IC50 0.01 Preclinical
CHEMBL430266 9.85 IC50 0.14 Preclinical
CHEMBL1366322 8.8 IC50 1.6 Preclinical
CHEMBL408120 8.47 Ki 3.4 Preclinical
CHEMBL406220 8.35 Ki 4.5 Preclinical
CHEMBL405248 8.1 Ki 8.0 Preclinical
CHEMBL261577 8.08 Ki 8.4 Preclinical
CHEMBL427915 7.76 Ki 17.3 Preclinical
CHEMBL406283 7.71 Ki 19.6 Preclinical
CHEMBL280487 7.7 IC50 20.0 Preclinical
Distribution

pChEMBL Value Distribution

2
5.0
6
5.5
0
6.0
3
6.5
9
7.0
7
7.5
4
8.0
3
8.5
4
9.0
1
9.5
pChEMBL
Assay Landscape

Assay Landscape

34
Total Assays
24
Tested Compounds
1
Assay Types
Binding — 34 assays, 24 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 33 24 7.6
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine